Shattuck Labs, Inc. Profile Avatar - Palmy Investing

Shattuck Labs, Inc.

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the trea…

Biotechnology
US, Austin [HQ]
Supply · Problems · Premarket · Compliance

Supply Analysis

End of STTK's Analysis
CIK: 1680367 CUSIP: 82024L103 ISIN: US82024L1035 LEI: - UEI: -
Secondary Listings
STTK has no secondary listings inside our databases.